EN
HI
Brawn Biotech Chart
Brawn Biotech Share Key Metrics
Volume
0.00
Market Cap
6.32 CR
LTQ@LTP
0@21.05
ATP
0
Var Margin
53.5 %
Circuit Range
20-22.1
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Summary
Brawn Biotech share price is ₹21.05 as of 6 Jun, 2026. The stock Brawn Biotech intraday movement has stayed between ₹00 and ₹00, while on a 52-week basis,Brawn Biotech price 52 week high is ₹24.37 & its 52 week low is ₹16.15.
In terms of trading activity, Brawn Biotech has recorded a volume of 0 shares, The Brawn Biotech has a market cap of ₹3000300 CR. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹21.05.
Brawn Biotech operates within a circuit range of ₹20.00 – ₹22.10, with a Value of ₹0.00. The Delivery Percentage for the day is 0%. Additionally, Brawn Biotech currently falls under the No framework, and trades with a market lot size of 1.
Brawn Biotech Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
39.79
Sector P/B
2.24
Sec. Div. Yield
77.36
Brawn Biotech Resistance and Support
Pivot 21.05
Resistance
First Resistance
21.05
Second Resistance
21.05
Third Resistance
21.05
Support
First Support
21.05
Second Support
21.05
Third Support
21.05
Brawn Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Audited Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
Brawn Biotech News
Brawn Biotech Ltd - 530207 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On 29Th May 2026, And Submissions Of Audited Financial Results For The Quarter And Year Ended 31.03.2026
Brawn Biotech reported audited financial results for FY26, with revenue reaching ₹17.43 crores, up 28.58% YoY. The company achieved a net profit of ₹0.94 crore for the year, a significant turnaround from a net loss of ₹1.80 crores in FY25.
May 29 2026 16:18:55
Brawn Biotech Ltd - 530207 - Board Meeting Intimation for Board Meeting To Consider And Approve Inter Alia The Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026.
Brawn Biotech's Board of Directors is scheduled to meet on May 29, 2026. The agenda includes the consideration and approval of the audited financial results for the quarter and financial year ended March 31, 2026.
May 21 2026 12:50:55
Brawn Biotech Management
| Name | Position |
|---|---|
| Mayank Jain | Non Executive Independent Director |
| Pooja Jha | Non Executive Independent Director |
Brawn Biotech Similar Stocks
Flora Corporation Ltd.
7.45
0.00 (0.00%)
Diksha Greens Ltd.
1.12
0.00 (0.00%)
Jayatma Enterprises Ltd.
68.81
1.34 (1.99%)
Gratex Industries Ltd.
25.71
0.00 (0.00%)
Artemis ADR Marketplace Ltd.
66.97
0.00 (0.00%)
Amanaya Ventures Ltd.
19.00
0.80 (4.40%)
Shivansh Finserve Ltd.
9.23
0.43 (4.89%)
Amit International Ltd.
3.00
0.00 (0.00%)
Munoth Communication Ltd.
5.59
-0.29 (4.93%)
Olympic Cards Ltd.
3.00
-0.05 (1.64%)
Brawn Biotech FAQs
The Buying Price of Brawn Biotech share is 21.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brawn Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brawn Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brawn Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brawn Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Brawn Biotech’s valuation compare Sector P/E, P/B which are 39.79 & 2.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brawn Biotech is 6.32 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brawn Biotech share price is 24.37 & 16.15. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brawn Biotech belongs to the Miscellaneous sector.
Made for Traders.
Trusted by Investors.
Download FinX — trade confidently, invest
smarter, track everything.
